1. Home
  2. OPTN vs IROH Comparison

OPTN vs IROH Comparison

Compare OPTN & IROH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTN
  • IROH
  • Stock Information
  • Founded
  • OPTN 2010
  • IROH 2021
  • Country
  • OPTN United States
  • IROH United States
  • Employees
  • OPTN N/A
  • IROH N/A
  • Industry
  • OPTN Biotechnology: Pharmaceutical Preparations
  • IROH
  • Sector
  • OPTN Health Care
  • IROH
  • Exchange
  • OPTN Nasdaq
  • IROH Nasdaq
  • Market Cap
  • OPTN 78.4M
  • IROH 91.2M
  • IPO Year
  • OPTN 2017
  • IROH 2023
  • Fundamental
  • Price
  • OPTN $6.38
  • IROH $10.33
  • Analyst Decision
  • OPTN Strong Buy
  • IROH
  • Analyst Count
  • OPTN 3
  • IROH 0
  • Target Price
  • OPTN $16.67
  • IROH N/A
  • AVG Volume (30 Days)
  • OPTN 60.7K
  • IROH 48.8K
  • Earning Date
  • OPTN 03-06-2025
  • IROH 01-01-0001
  • Dividend Yield
  • OPTN N/A
  • IROH N/A
  • EPS Growth
  • OPTN N/A
  • IROH N/A
  • EPS
  • OPTN N/A
  • IROH 0.20
  • Revenue
  • OPTN $75,672,000.00
  • IROH N/A
  • Revenue This Year
  • OPTN $13.42
  • IROH N/A
  • Revenue Next Year
  • OPTN $38.54
  • IROH N/A
  • P/E Ratio
  • OPTN N/A
  • IROH $52.79
  • Revenue Growth
  • OPTN 5.13
  • IROH N/A
  • 52 Week Low
  • OPTN $4.82
  • IROH $9.97
  • 52 Week High
  • OPTN $31.50
  • IROH $11.11
  • Technical
  • Relative Strength Index (RSI)
  • OPTN 49.78
  • IROH N/A
  • Support Level
  • OPTN $5.16
  • IROH N/A
  • Resistance Level
  • OPTN $6.97
  • IROH N/A
  • Average True Range (ATR)
  • OPTN 0.66
  • IROH 0.00
  • MACD
  • OPTN 0.10
  • IROH 0.00
  • Stochastic Oscillator
  • OPTN 71.08
  • IROH 0.00

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

About IROH Iron Horse Acquisitions Corp. Common Stock

Iron Horse Acquisitions Corp is a blank check company.

Share on Social Networks: